CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(66 sites)
United States
Mayo Clinic Hospital, Phoenix, Arizona SCRI - Arizona Oncology Associates, PC-HOPE, Tucson, Arizona City of Hope National Medical Center, Duarte, California Providence St. Jude Medical Center, Fullerton, California UCLA - JCCC Clinical Research Unit, Los Angeles, California Stanford Cancer Center, Palo Alto, California SCRI - Sansum Clinic, Santa Barbara, California Smilow Cancer Hospital at Yale - New Haven, New Haven, Connecticut Mayo Clinic Florida, Jacksonville, Florida Winship Cancer Institute, Emory University, Atlanta, Georgia University of Chicago Medical Center, Chicago, Illinois SCRI - Maryland Oncology Hematology, P.A., Annapolis, Maryland Massachusetts General Hospital, Boston, Massachusetts SCRI - Minnesota Oncology Hematology, P.A., Minneapolis, Minnesota University of Minnesota, Minneapolis, Minnesota Mayo Clinic, Rochester, Minnesota Washington University, St Louis, Missouri Rutgers Cancer Institute, New Brunswick, New Jersey Duke Cancer Center, Durham, North Carolina The James Cancer Hospital and Solove Research Institute - Ohio State University, Columbus, Ohio Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, Oklahoma SCRI - Northwest Cancer Specialists, P.C., Portland, Oregon SCRI - Alliance Cancer Specialists, PC, Doylestown, Pennsylvania University of Pennsylvania, Philadelphia, Pennsylvania SCRI - Texas Oncology, Fort Worth, Texas SCRI - Virginia Oncology Associates, Norfolk, Virginia Australia
Monash Medical Centre, Clayton, Melbourne Blacktown Hospital, Blacktown, New South Wales Icon Cancer Centre Chermside, Chermside, Queensland Flinders Medical Centre, Bedford Park, South Australia Linear Clinical Research, Perth, Western Australia Austria
Medizinische Universitat Landeskrankenhaus Graz, Graz, Styria Universitatsklinik Innsbruck, Innsbruck, Tyrol Ordensklinikum Linz, Linz, Upper Austria Belgium
Antwerp University Hospital (UZA), Edegem, Antwerp Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert, Brussels Capital UZ Leuven, Leuven, Flemish Brabant CHU Liège, Liège, Wallonia Canada
BC Cancer - Abbotsford, Abbotsford British Columbia, British Columbia British Columbia Cancer Agency (BC Cancer, part of the Provincial Health Services Authority), Vancouver, British Columbia Sunnybrook Research Institute, Toronto, Ontario Princess Margaret Cancer Centre - University Health Network (UHN), Toronto, Ontario Hospital Maisonneuve Rosemont, Montreal, Quebec Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec McGill University Health Centre (MUHC) - Royal Victoria Hospital, Montreal, Quebec France
Centre Leon Berard, Lyon, Auvergne- Rhôn-Alpes Institut de Cancérologie de l'Ouest, Saint-Herblain, Pays de la Loire Region Institut Gustave Roussy, Villejuif, Île-de-France Region Germany
Universitatsklinikum Heidelberg, Heidelberg, Baden-Wurttenberg Universitätsklinikum Erlangen, Erlangen, Bavaria Charité Universitätsmedizin Berlin, Berlin, State of Berlin Ireland
Start Dublin - Mater Misericordiae University Hospital, Dublin, Leinster St. James Hospital, Dublin, Leinster Italy
IRCCS Giovani Paolo II - Instituto Oncologico, Bari, Apulia Humanitas San Pio X, Milan, Milano Nuovo Ospedale di Prato S Stefano, Prato, Prato Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Rome Singapore
National University Cancer Institute, Singapore, Singapore National Cancer Centre, Singapore, Singapore Curie Oncology (Farrer), Singapore, Singapore South Korea
Seoul National University Hospital, Seoul, Gwanak-gu The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Seocho-Gu Yonsei University Health System, Severance Hospital, Seoul, Seodaemun-Gu Asan Medical Center, Seoul, Songpa-Gu Spain
Institut Catalá d'Oncologia de Girona, Girona, Catalonia Age range
18 Years and older
Last updated December 2025